[1]
KALA P et al. 2026. ADJUNCT SYNBIOTIC THERAPY WITH VILDAGLIPTIN-METFORMIN IMPROVES GLYCEMIC CONTROL, INSULIN SENSITIVITY, AND COST-EFFICIENCY IN ELDERLY PATIENTS WITH TYPE 2 DIABETES. Asian Journal of Pharmaceutical and Clinical Research. 19, 1 (Jan. 2026), 164–174. DOI:https://doi.org/10.22159/ajpcr.2026v19i1.56643.